High-Precision Non-Contact Plasmon-Induced Intracellular Delivery

高精度非接触式等离激元诱导细胞内递送

基本信息

  • 批准号:
    10661807
  • 负责人:
  • 金额:
    $ 24.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-22 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

ABSTRACT The recent emergence of robust genome editing methods (CRISPR associated targeted nuclease technologies) and their applications to stem cells has led to revolutionary breakthrough in the research and development of next-generation gene-editing therapies. In order to facilitate the transfection, gene-editing materials need to be delivered into cells in a rapid, efficient, and safe manner. Although some of the physical and biochemical methods for intracellular delivery are now used routinely in laboratory settings, issues with efficiency, throughput, and toxicity have limited their clinical implementations for universal delivering all-sizes of cargos into all-types of cells. To directly address the aforementioned challenges, this proposal aims to develop a high-precision plasmon-induced intracellular delivery scheme which utilizes the highly localized and intensified electromagnetic field in the close proximity of the plasmonic nanopipettes. The goal is to develop an integrated platform, with an emphasis on stem cell gene-editing, for universal approach of intracellular delivery and characterization for all varieties of cargo and cell types with high-efficiency and -viability from single-cell to millions of cells. Two prototype platforms will be developed: i) plasmonic nanopipettes for non-contact intracellular delivery through combining with scanning ion conductance microscopy; and ii) Parallelization of plasmonic nanopipettes via inertial microfluidics. Successfully completion of these two aims would lead to realization of universal intracellular delivery without physically penetrating the cell membranes, with single-cargo, single-cell precision. Furthermore, near-field optical sensing will be introduced into the developed platforms. It will provide a direct route to non-invasive, continuous, label-free biosensing with single-molecule sensitivity. Therefore, not only the fundamental mechanism of the plasmon-induced delivery will be interrogated, but it will also provide an in-situ feedback to further improvement of the developed platforms.
摘要 最近出现的强大的基因组编辑方法(CRISPR相关的靶向核酸酶技术) 以及它们在干细胞中的应用,导致了研究和开发的革命性突破, 下一代基因编辑疗法为了便于转染,需要将基因编辑材料 以快速、有效和安全的方式递送到细胞中。虽然一些物理和生物化学的 细胞内递送的方法现在在实验室环境中常规使用,但是效率,通量, 和毒性限制了它们的临床应用, 细胞 为了直接应对上述挑战,该提案旨在开发一种高精度的 等离子体诱导的细胞内递送方案,其利用高度局部化和增强的 在等离子纳米移液管附近的电磁场。目标是开发一个综合的 平台,重点是干细胞基因编辑,用于细胞内递送的通用方法, 所有种类的货物和细胞类型的表征具有高效率和活力,从单细胞到 数百万个细胞。将开发两个原型平台:i)用于非接触式等离子体纳米移液管, 通过与扫描离子电导显微镜结合的细胞内递送;和ii) 等离子纳米移液管通过惯性微流体。成功地实现这两个目标将导致 - 实现通用的细胞内递送而不物理穿透细胞膜, 单货物单细胞精确度此外,近场光学传感将被引入到开发的 平台它将为单分子非侵入性、连续、无标记的生物传感提供一条直接途径 灵敏度因此,不仅等离子体诱导的递送的基本机制将被询问, 但它也将提供现场反馈,以进一步改进已开发的平台。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Large-Scale Soft-Lithographic Patterning of Plasmonic Nanoparticles.
  • DOI:
    10.1021/acsmaterialslett.0c00535
  • 发表时间:
    2021-03-01
  • 期刊:
  • 影响因子:
    11.4
  • 作者:
    Chiang N;Scarabelli L;Vinnacombe-Willson GA;Pérez LA;Dore C;Mihi A;Jonas SJ;Weiss PS
  • 通讯作者:
    Weiss PS
Seeded-Growth Experiment Demonstrating Size- and Shape-Dependence on Gold Nanoparticle-Light Interactions.
  • DOI:
    10.1021/acs.jchemed.0c01150
  • 发表时间:
    2021-02-09
  • 期刊:
  • 影响因子:
    3
  • 作者:
    Vinnacombe-Willson GA;Chiang N;Weiss PS;Tolbert SH;Scarabelli L
  • 通讯作者:
    Scarabelli L
In Situ Shape Control of Thermoplasmonic Gold Nanostars on Oxide Substrates for Hyperthermia-Mediated Cell Detachment.
  • DOI:
    10.1021/acscentsci.0c01097
  • 发表时间:
    2020-11-25
  • 期刊:
  • 影响因子:
    18.2
  • 作者:
    Vinnacombe-Willson GA;Chiang N;Scarabelli L;Hu Y;Heidenreich LK;Li X;Gong Y;Inouye DT;Fisher TS;Weiss PS;Jonas SJ
  • 通讯作者:
    Jonas SJ
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Naihao Chiang其他文献

Naihao Chiang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Naihao Chiang', 18)}}的其他基金

High-Precision Non-Contact Plasmon-Induced Intracellular Delivery
高精度非接触式等离激元诱导细胞内递送
  • 批准号:
    10813943
  • 财政年份:
    2021
  • 资助金额:
    $ 24.65万
  • 项目类别:
High-Precision Non-Contact Plasmon-Induced Intracellular Delivery
高精度非接触式等离激元诱导细胞内递送
  • 批准号:
    9806813
  • 财政年份:
    2019
  • 资助金额:
    $ 24.65万
  • 项目类别:

相似国自然基金

基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
  • 批准号:
    82302715
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
  • 批准号:
    31200592
  • 批准年份:
    2012
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
  • 批准号:
    24K10442
  • 财政年份:
    2024
  • 资助金额:
    $ 24.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
  • 批准号:
    23K15297
  • 财政年份:
    2023
  • 资助金额:
    $ 24.65万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Fanconi anemia経路に着目したiPS細胞における高レベル複製ストレスの原因解明
阐明 iPS 细胞中高水平复制应激的原因,重点关注范可尼贫血途径
  • 批准号:
    23K14452
  • 财政年份:
    2023
  • 资助金额:
    $ 24.65万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Analysis of the mechanism of hemolytic anemia in canine babesiosis and development of novel therapeutic measures
犬巴贝斯虫病溶血性贫血机制分析及新治疗措施开发
  • 批准号:
    23KJ0074
  • 财政年份:
    2023
  • 资助金额:
    $ 24.65万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Mobile phone-based screening for anemia in young children in western Kenya
基于手机的肯尼亚西部幼儿贫血筛查
  • 批准号:
    10752968
  • 财政年份:
    2023
  • 资助金额:
    $ 24.65万
  • 项目类别:
Brain blood flow, oxygenation, and cognition in adult onset iron deficiency anemia
成人缺铁性贫血的脑血流量、氧合和认知
  • 批准号:
    10735765
  • 财政年份:
    2023
  • 资助金额:
    $ 24.65万
  • 项目类别:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
范可尼贫血血液疾病和骨髓衰竭中的染色质状态改变
  • 批准号:
    10735366
  • 财政年份:
    2023
  • 资助金额:
    $ 24.65万
  • 项目类别:
Accuracy and Feasibility of Non-Invasive Anemia Screening Assistant (ASIST) Device in Resource-Limited Settings
资源有限环境中非侵入性贫血筛查辅助 (ASIST) 设备的准确性和可行性
  • 批准号:
    10575222
  • 财政年份:
    2023
  • 资助金额:
    $ 24.65万
  • 项目类别:
Liver-Gut Axis in Neonatal Anemia and Its Role in RBC Transfusion Associated Gut Injury
新生儿贫血中的肝肠轴及其在红细胞输注相关肠道损伤中的作用
  • 批准号:
    10583807
  • 财政年份:
    2023
  • 资助金额:
    $ 24.65万
  • 项目类别:
A Sample-to-Answer Point-of-Care Diagnostic for Recently Transfused Sickle Cell Anemia Patients in Low Resource Settings
针对资源匮乏地区最近输血的镰状细胞性贫血患者的从样本到答案的护理点诊断
  • 批准号:
    10564553
  • 财政年份:
    2023
  • 资助金额:
    $ 24.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了